Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 3 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in PLN
The 4 analysts offering 12 month price targets for Ryvu Therapeutics SA have a median target of 74.25, with a high estimate of 99.30 and a low estimate of 67.00. The median estimate represents a 37.25% increase from the last price of 54.10.
High | 83.5% | 99.30 |
Med | 37.2% | 74.25 |
Low | 23.8% | 67.00 |
Earnings history & estimates in PLN
Average growth rate | -25.83% |
More ▼
Revenue history & estimates in PLN
Average growth rate | +17.16% |
Average growth rate | +8.34% |
More ▼